Three Nigerians win awards for medical innovation

Three Nigerian researchers who have developed, respectively, a typhoid fever vaccine, micro-needles and an anti-snake venom have been awarded prizes by the International Institute for Training, Research and Economic Development (IITRED).
“The prizes were handed out at an awards ceremony in Abuja on Friday.
“The recipients are Professor Samuel Garba of the Federal University of Technology, Minna, who developed the typhoid vaccine, and Dr Ololade Olatunji of University of Lagos, who developed micro-needles from fish scales.
“The third recipient is Professor John Aguiyi of the University of Jos, who developed the anti-snake venom.
“The chairman of IITRED, Dr Hassan Adamu, said that the awards were meant to encourage and promote local research to provide solutions to societal needs.
““Each year, IITRED reaches out to institutions in Nigeria to request for research nominations in areas that concern the society in order to stimulate demand-driven studies,’’ Dr Adamu said.
““By doing this, we hope that some of the challenges bedeviling our quest for industrial growth will be solved through the findings of our outstanding researchers.
“Promoting science
“Nigeria’s Minister for Science and Technology, Dr Ogbonnaya Onu, lauded IITRED for its gesture in promoting innovations.
“Dr Onu’s remarks were relayed by Mr Adeneye Talabi, the Director of Science and Technology in the ministry, who also urged IITRED to extend its awards to the area of engineering.
“He pledged the ministry’s commitment at promoting science and technology and encouraging innovations and explained that government had set up a presidential committee on Local Inventions and Innovations.
“In his research presentation, Garba, who won the Outstanding Medical Research Prize with his entry on “Development and Production of Typhoid Fever Vaccine,’’ said his work had undergone all necessary verifications.
“He said he was waiting for the National Agency for Food and Drug Administration and Control to finish with the registration of the vaccine before he could commercialise it.

SOURCE: AFRICA REVIEW